首页> 美国卫生研究院文献>other >Over-expression of Stat5b confers protection against diabetes in the non-obese diabetic (NOD) mice via up-regulation of CD4+CD25+ regulatory T cells
【2h】

Over-expression of Stat5b confers protection against diabetes in the non-obese diabetic (NOD) mice via up-regulation of CD4+CD25+ regulatory T cells

机译:STAT5B的过度表达通过CD4 + CD25 +调节T细胞的上调来赋予非肥胖糖尿病(NOD)小鼠对非肥胖糖尿病(NOD)小鼠的糖尿病的保护

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The signal transducers and activators of transcription (STAT) family of proteins play a critical role in cytokine signaling required for fine tuning of immune regulation. Previous reports showed that a mutation (L327M) in the Stat5b protein leads to aberrant cytokine signaling in the NOD mice. To further elaborate the role of Stat5b in diabetes, we established a NOD transgenic mouse that over-expresses the wild type Stat5b gene. The incidences of spontaneous diabetes as well as cyclophosphamide-induced diabetes were significantly reduced and delayed in the Stat5b transgenic NOD mice compared to their littermate controls. The total cell numbers of CD4+ T cells and especially CD8+ T cells in the spleen and pancreatic lymph node were increased in the Stat5b transgenic NOD mice. Consistent with these findings, CD4+ and CD8+ T cells from the Stat5b transgenic NOD mice showed a higher proliferation capacity and up-regulation of multiple cytokines including IL-2, IFN-γ, TNF-α and IL-10 as well as anti-apoptotic gene Bcl-xl. Furthermore, the number and proportion of CD4+CD25+ regulatory T cells were significantly increased in transgenic mice although in vitro suppression ability of the regulatory T-cells was not affected by the transgene. Our results suggest that Stat5b confers protection against diabetes in the NOD mice by regulating the numbers and function of multiple immune cell types, especially by up-regulating CD4+CD25+ regulatory T cells.
机译:蛋白质的信号转导子和转录激活子(STAT)家族在调节免疫调节所需的细胞因子信号传导中起着至关重要的作用。先前的报道表明,Stat5b蛋白中的突变(L327M)导致NOD小鼠中的细胞因子信号异常。为了进一步阐明Stat5b在糖尿病中的作用,我们建立了过表达野生型Stat5b基因的NOD转基因小鼠。与同窝对照相比,Stat5b转基因NOD小鼠的自发性糖尿病以及环磷酰胺诱导的糖尿病的发生率显着降低和延迟。 Stat5b转基因NOD小鼠脾脏和胰腺淋巴结中CD4 + T细胞的总数,尤其是CD8 + T细胞的总数增加。与这些发现一致的是,来自Stat5b转基因NOD小鼠的CD4 + 和CD8 + T细胞显示出更高的增殖能力并上调了多种细胞因子,包括IL-2,IFN -γ,TNF-α和IL-10以及抗凋亡基因Bcl-xl。此外,尽管调节性T细胞的体外抑制能力不受其影响,但转基因小鼠中CD4 + CD25 + 调节性T细胞的数量和比例显着增加。转基因。我们的结果表明,Stat5b通过调节多种免疫细胞的数量和功能,特别是通过上调CD4 + CD25 + 调节性T来赋予NOD小鼠抗糖尿病的保护作用细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号